Home
Join EHTG
Login
RSS Feed
Twitter
About Us
EHTG Meeting 2021
Welcome
Programme Overview
Register Your Interest
Other Events
Past Meetings
4th Meeting 2019
3rd Meeting 2018
2nd Meeting 2017
1st Meeting 2016
Collaborative Studies
The Prospective Lynch Syndrome Database
Guidelines
Publications
Membership
Home
>
Past meetings
>
3rd Meeting 2018
>
Programme
>
Working Group – Pathology and Immunology
Working Group – Pathology and Immunology
Date
: Tuesday 25 September 2018
Time
: 08:00 – 10:30
Time
Session
08:00 – 08:30
Towards a vaccine against microsatellite-unstable cancers – Magnus von Knebel Doeberitz (Germany)
08:30 – 09:00
N30: Life-long immune surveillance and immunoediting – evidence from Lynch syndrome cancers – Matthias Kloor (Germany)
09:00 – 09:30
The balance between cytotoxic T-cell lymphocytes and immune checkpoint expression determines prognosis in colon tumours – Alex Duval (France)
09:30 – 09:40
Discussion
09:40 – 10:30
Pathology and Immunology Abstracts
(8 mins for presentation + 4 mins for questions)
09:40 – 09:52
N29: New treatment possibilities for Lynch syndrome-associated cancer? – Christina Therkildsen (Denmark)
09:52 – 10:04
N78: In contrast to subjects with Lynch Syndrome, the adenomatous polyps from subjects with sporadic MSI-high tumours have normal expression of MMR proteins – Zohar Levi (Israel)
10:04 – 10:16
N48: Molecular tumor testing in Lynch-like patients reveals de novo mosaic DNA mismatch repair gene pathogenic variants transmitted to offspring – Chrystelle Colas (France)
10:16 – 10:28
N51: A novel tool for quantitative analysis of microsatellite mutations and frameshift neoantigens – Alexej Ballhausen (Germany)
Past Meetings
4th Meeting 2019
Overview
Programme
(wh)y-EHTG Plenary Session
Missing the Target Plenary
Microbiome
Gynaecology
Genetics and Gene Panel Testing
Immunology and Pathology
Dermatology and Urology
Genetic Counselling
MMR / Variant Interpretation
Gastroenterology
Polyposis Syndromes
Clinical Management and Guidance
Collaborative Studies
Registries
Chemoprevention
Working Groups Reporting Back
Joint AsCAP/EHTG Therapeutic Prevention Session
State of the Art Lectures
Speakers and Faculty
3rd Meeting 2018
Programme
State of the Art Lectures
Working Group – Clinical
Working Group – EHTG Living Guidance
Working Group – European MMR Group
Working Group – Gastroenterology
Working Group – Gene Panel
Working Group – Genetics
Working Group – Pathology and Immunology
Working Group – Registries
Working Group – Surgery
Speakers and Faculty
Abstracts
2nd Meeting 2017
1st Meeting 2016
Programme
Thursday: Working Groups
Registries and Biobanks
MMR European Group
Surgery and Endoscopy
Chemoprevention for Polyposis Syndromes Workshop
VIC: Variant Interpretation Committee
Chemoprevention and Immunotherapy Workshop
Friday: Plenary Scientific Meeting
Saturday: Collaborative
Speakers
Abstracts
Organising Committee
Contact Information
European Hereditary Tumour Group Secretariat
0131 656 5635
Email
c/o Lindsays, Caledonian Exchange, 19A Canning Street, Edinburgh EH3 8HE, UK
Top